1. Home
  2. BIO vs CZR Comparison

BIO vs CZR Comparison

Compare BIO & CZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CZR
  • Stock Information
  • Founded
  • BIO 1952
  • CZR 1937
  • Country
  • BIO United States
  • CZR United States
  • Employees
  • BIO N/A
  • CZR N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CZR Hotels/Resorts
  • Sector
  • BIO Industrials
  • CZR Consumer Discretionary
  • Exchange
  • BIO Nasdaq
  • CZR Nasdaq
  • Market Cap
  • BIO 6.0B
  • CZR 5.4B
  • IPO Year
  • BIO N/A
  • CZR 1989
  • Fundamental
  • Price
  • BIO $243.98
  • CZR $28.38
  • Analyst Decision
  • BIO Strong Buy
  • CZR Strong Buy
  • Analyst Count
  • BIO 4
  • CZR 13
  • Target Price
  • BIO $324.25
  • CZR $44.00
  • AVG Volume (30 Days)
  • BIO 417.7K
  • CZR 5.4M
  • Earning Date
  • BIO 07-31-2025
  • CZR 07-29-2025
  • Dividend Yield
  • BIO N/A
  • CZR N/A
  • EPS Growth
  • BIO N/A
  • CZR N/A
  • EPS
  • BIO N/A
  • CZR N/A
  • Revenue
  • BIO $2,541,100,000.00
  • CZR $11,297,000,000.00
  • Revenue This Year
  • BIO N/A
  • CZR $3.33
  • Revenue Next Year
  • BIO $3.49
  • CZR $2.50
  • P/E Ratio
  • BIO N/A
  • CZR N/A
  • Revenue Growth
  • BIO N/A
  • CZR N/A
  • 52 Week Low
  • BIO $211.43
  • CZR $21.40
  • 52 Week High
  • BIO $387.99
  • CZR $45.93
  • Technical
  • Relative Strength Index (RSI)
  • BIO 60.94
  • CZR 54.86
  • Support Level
  • BIO $235.01
  • CZR $28.36
  • Resistance Level
  • BIO $246.50
  • CZR $29.81
  • Average True Range (ATR)
  • BIO 7.17
  • CZR 0.99
  • MACD
  • BIO 2.32
  • CZR 0.26
  • Stochastic Oscillator
  • BIO 90.49
  • CZR 70.59

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CZR Caesars Entertainment Inc.

Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.

Share on Social Networks: